These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 11704497

  • 1. Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Vidal S, Ros I, Monegal A, Bedini JL, Deulofeu R, Pons F, Muñoz-Gomez J, Ballesta AM.
    Bone; 2001 Nov; 29(5):447-52. PubMed ID: 11704497
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
    Peris P, Alvarez L, Vidal S, Martínez MA, Monegal A, Guañabens N.
    Clin Exp Rheumatol; 2007 Nov; 25(2):206-10. PubMed ID: 17543143
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biochemical response to bisphosphonate therapy in pagetic patients with skull involvement.
    Peris P, Alvarez L, Vidal S, Kasper D, Leeming DJ, Monegal A, Angeles Martínez M, Pons F, Guañabens N.
    Calcif Tissue Int; 2006 Jul; 79(1):22-6. PubMed ID: 16868670
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity.
    Pons F, Alvarez L, Peris P, Guañabens N, Vidal-Sicart S, Monegal A, Pavía J, Ballesta AM, Muños-Gómez J, Herranz R.
    Nucl Med Commun; 1999 Jun; 20(6):525-8. PubMed ID: 10451864
    [Abstract] [Full Text] [Related]

  • 8. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

  • 9. Components of biological variation of biochemical markers of bone turnover in Paget's bone disease.
    Alvarez L, RicOs C, Peris P, GuaNabens N, Monegal A, Pons F, Ballesta AM.
    Bone; 2000 Jun; 26(6):571-6. PubMed ID: 10831927
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L, Peris P, Guañabens N, Vidal S, Ros I, Pons F, Filella X, Monegal A, Muñoz-Gomez J, Ballesta AM.
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [Abstract] [Full Text] [Related]

  • 14. Biochemical markers of bone turnover in Paget's disease of bone.
    Delmas PD.
    J Bone Miner Res; 1999 Oct; 14 Suppl 2():66-9. PubMed ID: 10510216
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.
    Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T.
    Bone; 2004 Jul; 35(1):224-30. PubMed ID: 15207761
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
    Ebert W, Muley T, Herb KP, Schmidt-Gayk H.
    Anticancer Res; 2004 Jul; 24(5B):3193-201. PubMed ID: 15510610
    [Abstract] [Full Text] [Related]

  • 19. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P, Alvarez L, Monegal A, Guañabens N, Durán M, Pons F, Martínez de Osaba MJ, Echevarría M, Ballesta AM, Muñoz-Gómez J.
    Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone.
    Bonnin MR, Moragues C, Nolla JM, Lirón FJ, Roig-Escofet D, Navarro MA.
    Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.